Cargando…
Antidotes, antibody-mediated immunity and the future of pharmaceutical product development
If new scientific knowledge is to be more efficiently generated and applied toward the advancement of health, human safety must be more effectively addressed in the conduct of research. Given the present difficulties of accurately predicting biological outcomes of novel interventions in vivo, the im...
Autor principal: | Caoili, Salvador Eugenio C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859750/ https://www.ncbi.nlm.nih.gov/pubmed/23291934 http://dx.doi.org/10.4161/hv.22858 |
Ejemplares similares
-
Beyond new chemical entities: Advancing drug development based on functional versatility of antibodies
por: Caoili, Salvador Eugenio C, et al.
Publicado: (2014) -
Benchmarking B-Cell Epitope Prediction with Quantitative Dose-Response Data on Antipeptide Antibodies: Towards Novel Pharmaceutical Product Development
por: Caoili, Salvador Eugenio C.
Publicado: (2014) -
On the Meaning of Affinity Limits in B-Cell Epitope Prediction for Antipeptide Antibody-Mediated Immunity
por: Caoili, Salvador Eugenio C.
Publicado: (2012) -
An antidote for Staphylococcus aureus pneumonia?
por: DeLeo, Frank R., et al.
Publicado: (2008) -
Drugs and pharmaceuticals: management of intoxication and antidotes
por: Smith, Silas W.
Publicado: (2010)